House Of Lords Validates Angiotech's Stent Patent
The U.K.'s highest court ruled against Angiotech's American competitor Conor Medsystems Inc., which was one of five companies to challenge Angiotech's patent for taxol stent coating in various lawsuits in Europe.
Angiotech's stent is designed to prevent restenosis, or scarring of the artery, by eluting the drug taxol.
The House of Lords...
To view the full article, register now.